Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
Abstract Background Melioidosis is an infectious disease caused by the bacterium Burkholderia pseudomallei. The two stages of melioidosis treatment are the intense intravenous phase and the oral eradication phase. Although co-trimoxazole has been in use for several years, the literature does not dem...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12941-023-00620-z |